Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.300
0.00 (0.00%)
May 5, 2026, 4:00 PM EDT - Market closed
DRMA's stock price has decreased by -85.06% in the past year and price targets may not have had time to catch up.
Dermata Therapeutics Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$10.00
Upside
+669.23%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Maintains $30 → $10 | Strong Buy | Maintains | $30 → $10 | +669.23% | Aug 21, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $60 → $30 | Strong Buy | Maintains | $60 → $30 | +2,207.69% | May 21, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $100 → $60 | Strong Buy | Maintains | $100 → $60 | +4,515.38% | Aug 21, 2024 |
| Maxim Group | Maxim Group | Strong Buy Maintains $2,400 → $600 | Strong Buy | Maintains | $2,400 → $600 | +46,053.85% | Mar 23, 2023 |
| Brookline Capital | Brookline Capital | Strong Buy Initiates $33,600 | Strong Buy | Initiates | $33,600 | +2,584,515.38% | Sep 21, 2021 |
| Maxim Group | Maxim Group | Strong Buy Initiates $21,600 | Strong Buy | Initiates | $21,600 | +1,661,438.46% | Sep 14, 2021 |